{"id":331172,"date":"2026-10-28T18:03:15","date_gmt":"2026-10-28T12:33:15","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/sudeep-pharma-q2-results-fy27-pat-52-crore\/"},"modified":"2026-10-28T18:03:15","modified_gmt":"2026-10-28T12:33:15","slug":"sudeep-pharma-q2-results-fy27-pat-52-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sudeep-pharma-q2-results-fy27-pat-52-crore\/","title":{"rendered":"Sudeep Pharma Q2 Results FY27: Net Profit Rises 10.75% to Rs 51.81 Cr, Revenue Rs 196.70 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Sudeep Pharma Q2 Results FY27 were declared on 28 October 2026 for the July to September 2026 quarter. On a Consolidated basis, revenue grew 20.92% YoY to Rs 196.70 Cr, and net profit rose 10.75% YoY to Rs 51.81 Cr from Rs 46.78 Cr. Operating Profit increased 32.06% YoY to Rs 73.24 Cr, ahead of the pace of net profit.<\/p>\n<\/div>\n

Sudeep Pharma Ltd<\/a> (SUDEEPPHRM) announced Q2 Results FY27 on 28 October 2026, covering the company’s July to September quarter. The results date came with consolidated results showing revenue of Rs 196.70 Cr and net profit of Rs 51.81 Cr, and Sudeep Pharma Q2 Results FY27 compare both with the quarter a year before.<\/p>\n

This results analysis from Univest looks at how revenue, Operating Profit and net profit moved across Sudeep Pharma Q2 Results, and then at the business drivers, outlook and risks. The Financial Highlights table opens the analysis, with the key takeaways and detailed commentary after it.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n